These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8724891)

  • 21. C1q-bearing immune complexes induce IL-8 secretion in human umbilical vein endothelial cells (HUVEC) through protein tyrosine kinase- and mitogen-activated protein kinase-dependent mechanisms: evidence that the 126 kD phagocytic C1q receptor mediates immune complex activation of HUVEC.
    Xiao S; Xu C; Jarvis JN
    Clin Exp Immunol; 2001 Sep; 125(3):360-7. PubMed ID: 11531942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C1q, a subunit of the first component of complement, enhances antibody-mediated apoptosis of cultured rat glomerular mesangial cells.
    Sato T; van Dixhoorn MG; Heemskerk E; van Es LA; Daha MR
    Clin Exp Immunol; 1997 Sep; 109(3):510-7. PubMed ID: 9328130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Production and characterization of a murine monoclonal IgM antibody to human C1q receptor (C1qR).
    Ghebrehiwet B
    J Immunol; 1986 Jul; 137(2):618-24. PubMed ID: 3487576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo degradation of rat C1q induced by intravenous injection of soluble IgG aggregates.
    Veerhuis R; van Es LA; Daha MR
    Immunology; 1985 Apr; 54(4):801-10. PubMed ID: 3872261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Possible mechanisms of degradation of C1q in vivo and in vitro: role of macrophages.
    Daha MR
    Behring Inst Mitt; 1989 Jul; (84):42-6. PubMed ID: 2529843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complement enhances the elimination of soluble aggregates of IgG by rat liver endothelial cells in vivo.
    Bogers WM; van Rooijen N; Janssen DJ; van Es LA; Daha MR
    Eur J Immunol; 1993 Feb; 23(2):433-8. PubMed ID: 8436178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of cellular Fc and C3 receptors on the complement-dependent degradation of stable soluble immunoglobulin aggregates by normal and trypsin-treated peritoneal macrophages.
    Daha MR; van Es LA
    Immunology; 1982 Sep; 47(1):203-9. PubMed ID: 7118161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the C1q receptor on a human macrophage cell line, U937.
    Arvieux J; Reboul A; Bensa JC; Colomb MG
    Biochem J; 1984 Mar; 218(2):547-55. PubMed ID: 6370241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Down-regulation of Fc receptor expression in guinea pig peritoneal exudate macrophages by muramyl dipeptide or lipopolysaccharide.
    Yagawa K; Kaku M; Ichinose Y; Nagao S; Tanaka A; Aida Y; Tomoda A
    J Immunol; 1985 Jun; 134(6):3705-11. PubMed ID: 2985692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-molecular weight C1q-binding immunoglobulin G in patients with systemic lupus erythematosus consists of autoantibodies to the collagen-like region of C1q.
    Uwatoko S; Mannik M
    J Clin Invest; 1988 Sep; 82(3):816-24. PubMed ID: 3262124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the human neutrophil C1q receptor and functional effects of free ligand on activated neutrophils.
    Eggleton P; Ghebrehiwet B; Coburn JP; Sastry KN; Zaner KS; Tauber AI
    Blood; 1994 Sep; 84(5):1640-9. PubMed ID: 8068954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C1q--how many functions? How many receptors?
    Eggleton P; Reid KB; Tenner AJ
    Trends Cell Biol; 1998 Nov; 8(11):428-31. PubMed ID: 9854308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C1q enhancement of antibody-dependent granulocyte-mediated killing of nonphagocytosable targets in vitro.
    Hamada A; Young J; Chmielewski RA; Greene BM
    J Clin Invest; 1988 Sep; 82(3):945-9. PubMed ID: 2843577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C1q augments platelet activation in response to aggregated Ig.
    Peerschke EI; Ghebrehiwet B
    J Immunol; 1997 Dec; 159(11):5594-8. PubMed ID: 9548501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of a high-affinity binding site for the globular head regions of the C1q complement protein on a human diploid fibroblast subtype.
    Bordin S; Page RC
    Mol Immunol; 1989 Jul; 26(7):677-85. PubMed ID: 2789337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interactions of human mesangial cells with IgA and IgA-containing immune complexes.
    Novak J; Vu HL; Novak L; Julian BA; Mestecky J; Tomana M
    Kidney Int; 2002 Aug; 62(2):465-75. PubMed ID: 12110007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of C1q by monoclonal antibodies.
    Heinz HP; Loos M
    Behring Inst Mitt; 1984 Nov; (76):42-58. PubMed ID: 6335397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kupffer cell depletion in vivo results in preferential elimination of IgG aggregates and immune complexes via specific Fc receptors on rat liver endothelial cells.
    Bogers WM; Stad RK; Janssen DJ; van Rooijen N; van Es LA; Daha MR
    Clin Exp Immunol; 1991 Nov; 86(2):328-33. PubMed ID: 1934600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Binding of complement component C1q to anti-beta2 glycoprotein I antibodies from patients with antiphospholipid syndrome.
    Odorczuk M; Keil LB; DeBari VA
    Inflamm Res; 1999 Oct; 48(10):524-6. PubMed ID: 10563468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of morphine on uptake of immunoglobulin G complexes by mesangial cells and macrophages.
    Singhal PC; Pan C; Gibbons N
    Am J Physiol; 1993 May; 264(5 Pt 2):F859-66. PubMed ID: 8498540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.